The Impact of Collaborative and Risk Sharing Innovation Approaches on Clinical and Regulatory Cycle Times

A discussion of the consequences of mergers and acquisitions on medical product development times with Joseph DiMasi and Kenneth Getz of the Tufts Center for the Study of Drug Development. Click here to read their article from the July 2014 issue of TIRS.